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Abstract
Background: Liver cancer is one of most commonly diagnosed cancers among Koreans. Chronic
hepatitis B virus (HBV) infection is a major risk factor for liver cancer. HBV infection can be
prevented by effective screening and vaccination programs. The purpose of this study is to examine
the status of HBV infection and the predictors associated with HBV vaccination.
Methods: The study population was derived from the 2005 Korea National Cancer Screening
Survey (KNCSS). The KNCSS is an annual cross-sectional survey that uses a nationally-
representative random sampling to investigate cancer screening rates. A total of 1,786 Koreans
over 40 years of age participated in this study.
Results: Of all the participants, 5.9% reported HBV positive (HBsAg+, HBsAb-), 41.8% were HBV
negative but protected (HBsAg-, HBsAb+), and 52.3% were unprotected (HBsAg-, HBsAb-).
Among unprotected individuals (n = 934), 23.1% reported to have received the vaccination. About
half of those who had vaccinations completed the 3-shot vaccine series. In multiple analyses,
education, having private cancer insurance, alcohol use, having regular check-up, and doing regular
exercise were associated with completed HBV vaccination.
Conclusion: This study result suggests that we need a liver cancer education program to increase
HBV awareness and to increase the liver cancer prevention message among low educated
populations.
Background
Worldwide, two billion people have been infected with
hepatitis B virus (HBV), 360 million have chronic infec-
tion, and 600,000 die each year from HBV-related liver
disease or hepatocellular carcinoma (HCC) [1]. HBV
infection is responsible for 70 to 80% of primary HCC. A
meta-analysis of 32 studies published between 1993 and
1997 reported that a summary odds ratio (OR) was 13.7
for development of HCC among people chronically
infected with HBV [2]. Several epidemiological studies
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also strongly support the important role of chronic HBV
infection early in life for the subsequent development of
HCC [3].
In Korea, liver cancer ranks 3rd among causes of cancer
deaths [4] and highest mortality in the world. Liver cancer
is one of most commonly diagnosed cancers in Korean
men [5]. In response to the higher prevalence of liver can-
cer mortality in Korea, previous studies have examined
the status of HBV infection in a representative [6-8] or
non-random sample of health care workers [9]. The prev-
alence of HBV infection in Korea was 8% to 15% before
the introduction of hepatitis B vaccination in the early
1980s [10]. In 1985, government employees, school
teachers and their dependants were recommended to
receive the vaccination against HBV on a voluntary basis
for those with negative results on both HBsAg and anti-
HBs by the Korean Medical Insurance Corporation (now
a part of the National Health Insurance Corporation).
Since the Korean government has carried out a program of
vaccination against hepatitis B, and the prevalence of
HBsAg seropositivity has fallen [11]. However, the HBV
infection rate is still high, ranging from 2% to 8.9% [7-9].
For example, from the third Korea National Health and
Nutrition Examination Survey (KNHANES III), Koreans
over 40 years of ages reported that the prevalence of HBV
infection was 4.0% (4.2% for men and 3.8%for women)
[8]. In a prospective cohort study, about 5% of Korean
men over 30 years of age reported HBV infection [6].
Therefore, in 2003 the Korean government and National
Health Insurance Corporation introduced the nationwide
liver cancer screening program as a part of the National
Cancer Screening Program (NCSP) for low income group.
The NCSP provides Medical Aid recipients and National
Health Insurance beneficiaries within the lower 50%
income bracket with free-of-charge screening services for
liver cancer. The NCSP recommends liver cancer screening
every six months for men and women aged 40 years and
older who are at high risk for liver cancer such as liver cir-
rhosis, HBsAg positive, or anti-HCV positive, with alpha-
fetoprotein (AFP) and ultrasonography [12].
HBV vaccine is one of the most widely used vaccines and
the world's first cancer preventive vaccine [1]. The dra-
matic decrease of the HBV infection rate may reflect the
effectiveness of the HBV vaccination program that was
first licensed in the U.S. in 1981. Nevertheless, many
Koreans are neither aware of the status of HBV infection
nor aware of the importance of liver cancer prevention
though HBV vaccination. For example, about 74%
reported that they were unprotected after HBV screening
and only 13.2% received the HBV vaccination among
those unprotected [6]. Moreover, few studies have focused
on the factors associated with this secondary prevention
of liver cancer. Our study tried to fill this gap by identify-
ing the problems of HBV vaccinations from the national
sample in Korea.
The purpose of this paper is to examine the status of HBV
infection and the rate of HBV vaccination and to examine
factors associated with HBV vaccination among Koreans
using data from the 2005 Korean National Cancer Screen-
ing Survey (KNCSS).
Methods
Data and Sampling
This study was based on the 2005 Korean National Cancer
Screening Survey (KNCSS), an annual cross-sectional sur-
vey that uses a nationally-representative random sam-
pling to investigate Korean participation rates in cancer
screening for five common cancers: gastric, liver, colorec-
tal, breast, and cervix [13]. A total of 5132 men and
women were selected from the 2004 Resident of Registra-
tion Population data of the Korea National Statistical
Office using multistage random sampling, stratified
according to geographic area, age, and gender. This study
was approved by the Institutional Review Board of the
National Cancer Center, Korea.
Face-to-face interviews were performed in the subjects'
homes by investigators from a professional research
agency for two weeks from the 17th of August to the 3rd of
September in 2005. Interviews were completed by 2,052
subjects (response rate, 40.0%), aged ≥ 30 years, who had
not previously been diagnosed with cancer. We obtained
informed consent for participation in the study. The pop-
ulation for the current study was restricted to participants
aged 40 years and older (N = 1,786) since those aged ≥ 40
years were asked to report their liver cancer screening.
Measures
The measures of the status of HBV infection and HBV vac-
cination were assessed: (1) whether individuals had
infected hepatitis B virus, (2) whether they had HBV vac-
cinations, and (3) how many times they had received vac-
cinations. The major outcome of this study is whether
they had completed a series of vaccinations (0 = no, 1 =
yes).
Demographic variables included age (40-90 years), gen-
der, and employment status. Education attainment was
categorized into three groups (less than high school, high
school graduate, more than some college). Household
income was categorized into four groups based on
monthly household post-tax income (US $1 = 1000 won):
(1) <$1,000; (2) $1,000-1,999; (3) $2,000 - 2,999; and
(4) >$3,000. Residence was categorized into three includ-
ing metropolitan city, suburban, and rural.BMC Infectious Diseases 2009, 9:185 http://www.biomedcentral.com/1471-2334/9/185
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Questions about health insurance coverage and health
check-ups or usual sources of care were considered a proxy
for ability to afford, have access to, and use care. However,
except for some medical aid beneficiaries, all Koreans
(95.6%) are insured by the Korean National Health Insur-
ance (NHI) program. Private cancer insurance is becom-
ing very popular in Korea due to the insufficient coverage
of the NHI program and the high medical costs involved
in cancer treatment. Therefore, we measured health insur-
ance status by asking whether they have private cancer
insurance (0 = no; 1 = yes). We also measured the history
of health check-ups measured by asking whether partici-
pants had a regular health check-ups even though they
were not sick (0 = no, 1 = yes).
To measure the belief in cancer screening, participants
were asked about their opinion on whether cancer screen-
ing is helpful for early detection and treatment of cancer.
The response was on a four-point scale (1 = strongly agree,
4 = strongly disagree).
Health status was measured by self-reporting. To measure
health status, we asked respondents to rate their general
health status on a five-point scale (1 = very poor, 5 = excel-
lent). With regard to health behavior, we measured alco-
hol use and regular exercise. For alcohol use, we asked
participants if they had consumed alcohol within the past
30 days and categorized them into four groups: (1) no
drinks, (2) drink once a week (light drinker), (3) drink 2
or 6 days a week (moderate drinker), and (4) drink every
day (heavy drinker). Exercise was measured by asking:
"During the past month, other than your regular job, did
you participate in any physical activities or exercise such
as running, calisthenics, golf, gardening, or walking for
exercise (0 = no, 1 = yes)?"
Statistical analysis
We used logistic regression to examine the likelihood of
having completed a series of HBV vaccinations across var-
ious levels of predictors. First, we performed bivariate
analysis to determine which independent variables would
distinguish participants who had vaccinations. Then, we
conducted multivariate logistic regression analyses to
identify the most important predictors of having com-
pleted a series of HBV vaccinations, after adjusting for
other variables. We used SAS statistical software (version
9.1; SAS Institute Inc., Cary, NC). All reported odds ratios
(ORs) were considered significant at P < 0.05.
Results
Sample Characteristics
Demographic characteristics of respondents are shown in
Table 1. The sample consisted of 1,786 Korean age 40 and
older in Korea. The mean age was 52 years, ranging from
40 to 90 years. About 54% were female and about 40%
had less than a high school education. About two-thirds
were employed on a full-time or part-time basis. More
than 90% were married.
About 13% reported that they had a monthly income less
than $1000. The majority had national health insurance.
However, two-thirds had private cancer insurance. About
10% reported health status as poor to fair. About 3 out of
4 reported having had a regular check-up. More than half
did not drink alcohol in the past 30 days and about 6%
reported to drink everyday. About 56% engaged in regular
exercise.
Table 1: Characteristics of study population (n = 1786), Korea, 
2005
No %
Age (mean ± SD), range 51.8 ± 8.8 40-90
Gender
Males 826 46.2
Females 960 53.8
Education (missing = 25)
< High school 661 37.5
High school 819 46.5
Some college 252 14.3
College + 29 1.6
Employed (yes) 1095 61.3
Marital status
Married 1651 92.4
Sep/divorce/widow 104 5.8
Never married 31 1.7
Monthly income (missing = 33)
<$1500 462 26.4
$1500-2999 774 44.1
>$3000 517 29.5
Residence
Metropolitan City 844 47.3
City (suburban) 702 39.3
Rural 240 13.4
Health Insurance Type
National Health Insurance 1707 95.6
Medical Aids 79 4.4
Having private (supplementary) health insurance
No 591 33.1
Yes 1195 66.9
Self-reported health
Excellent 178 10.0
Very good 906 50.7
Good 509 28.5
Fair/Poor 193 10.8
Had a regular health check-up (= yes) 1302 72.9
Alcohol Use
None in the past 30 days 938 52.5
Light (1/week) 441 27.7
Moderate (2-6 day/week) 309 17.3
Heavy (every day) 98 5.5
Regular exercise (= yes) 1009 56.5BMC Infectious Diseases 2009, 9:185 http://www.biomedcentral.com/1471-2334/9/185
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Prevalence of HBV infection
Table 2 shows the status of HBV infection among Koreas
in 2005. A total of 1,786 participants over 40 years of age
reported the status of HBV infection and HBV vaccination.
Of all the participants, 5.9% (n = 106) reported HBV pos-
itive (HBsAg+, HBsAb-): males reported higher HBV posi-
tive than females (6.3% vs. 5.6%). This gender difference
was not statistically significant (χ2 = 2.17, df = 2, p = .34).
41.8% (n = 746) were HBV negative but protected
(HBsAg-, HBsAb+); 52.3% (n = 934) were unprotected
(HBsAg-, HBsAb-).
Table 3 shows the status of HBV vaccinations including
the number of vaccinations among those unprotected (n
= 934). About 23% (n = 216) of these unprotected indi-
viduals reported to have had vaccinations. About half of
those who had vaccinations completed the 3-shot vaccine
series. About one out of four received the first vaccination
and another one fourth had the second vaccination. More
than three-fourths (77%) did not receive any vaccination.
Factors Associated with HBV Vaccination
Among those unprotected (n = 934), education, alcohol
use, regular exercise, having health insurance, and regular
check-ups were associated with having completed a series
of HBV vaccinations (Table 4). Those with more than
some college education (OR = 2.52, 95% CI: 1.16, 5.43)
were more likely to have vaccinations than those with less
than high school education. Light drinkers were more
likely than non drinkers to have vaccinations (OR = 2.20,
95% CI: 1.32, 3.68). Those having no regular exercise
were less likely to have vaccinations than those having
regular exercise (OR = 0.61, 95% CI: 0.39, 0.94). Those
with private cancer insurance were more likely to have
vaccinations than those with no insurance (OR = 2.25,
95% CI: 1.34, 3.78). Those having regular check-ups were
more likely to have vaccinations than those without regu-
lar check-up (OR = 2.70, 95% CI: 1.57, 4.67).
Barriers to having HBV Vaccination
Those who had not had an HBV vaccination (n = 718)
were asked to describe the reasons for not having an HBV
vaccination (Table 5). No knowledge of HBV vaccination
was the most cited reason (44.1%) followed by put it off
(16%) and no time to have a vaccination (13%). About
11% said that an HBV infection is not a severe health
problem.
Discussion
This study is unique in its focus on liver cancer prevention
in a national sample of Koreans which can provide us a
more comprehensive picture of the distribution of HBV
infection in Korea. The prevalence of HBV infection was
5.9% (6.3% males and 5.6% females), which was compa-
rable to the previous epidemiological study of HBV infec-
tion in the 1998 Korean National Health and Nutrition
Survey [7]. The prevalence of HBsAg in that study was
5.1% (95% CI: 4.5-5.7) in males and 4.1% (95% CI: 3.6-
4.6) in females among those over 10 years of age. How-
ever, except for those under 20 years of age, the prevalence
of HBsAg was higher, at 5.8% (95% CI: 5.0-6.6) in males
and 4.4% (95% CI: 3.8-5.0) in females. In Korea, seropos-
itivity of HBsAg among children and adolescents less than
20 years of age was dramatically decreased to 2% because
of the vaccination program. Those less than 20 years of
age were mostly born after the introduction of the vacci-
nation program. Therefore, this suggests that Koreans over
40 years of age had a higher prevalence of HBV infection
than those younger than 20 years of age.
Two-fifth (41.8%) of the participants reported a protected
status and more than half (52.3%) were unprotected.
About one out of four had an HBV vaccination among
those unprotected. This study shows that the unprotected
rate was much lower than that in the earlier prospective
cohort study in late 1980s (73.8%) [6]. Moreover, the
HBV vaccination rate in this study is higher than that in
late 1980s (13.2%) [6]. It may be explained by the initia-
tion of the vaccination program in 1985 to encourage
HBV screening and vaccinations.
Educational attainment was associated with having vacci-
nations. Similarly, a study of Korean Americans showed
that those with high education had higher HBV screening
than those with low education [14]. The findings here are
consistent with that and support the positive effects of
higher level of education on getting vaccinations. Those
with low education levels may require special attention
since they are not aware of the importance of HBV vacci-
nations or do not have resources to use adequate health
Table 2: Self-report of status of HBV infection, 2005, Korea (n = 1786)
Male (n = 826) Female (n = 960) Total (n = 1786)
N% N % N %
HBsAg+ 52 6.3 54 5.6 106 5.9
HBsAg-/HBsAb+ (protected) 330 40.0 416 43.3 746 41.8
HBsAg-/HBsAb- (unprotected) 444 53.7 490 51.0 934 52.3
Chi-square statistics = 2.17, df = 2, p = .34BMC Infectious Diseases 2009, 9:185 http://www.biomedcentral.com/1471-2334/9/185
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services, including screening and vaccinations to prevent
liver cancer. Our data would argue for special programs to
target those with low education levels.
Consistent with previous studies of cancer control
[13,14], access to health care was also a strong predictor of
HBV vaccinations. We found that those with private can-
cer insurance had higher odds of having vaccinations.
Having private cancer insurance was an indicator of the
opportunity to obtain vaccinations or learn guidelines
from a health care provider.
Table 3: Status of HBV vaccination, 2005
Status of vaccination (n = 934) Number of vaccination (n = 216)
No vaccination 718 (76.9%) -
Vaccination 216 (23.1%) -
-3 times - 110 (50.9%)
-2 times - 55 (25.5%)
-1 time - 51 (23.6%)
Table 4: Logistic regression for having completed a series of HBV vaccinations (n = 934), Korea, 2005
Having completed HBV vaccination (n = 110)
% aOR(95% CI)
Age (mean ± SD) 52.4 ± 8.9 1.01 (0.98-1.04)
Gender
Male 14 1.00
Female 10 0.71 (0.40-1.25)
Education
< High school 10a 1.00
High school 13 1.43 (0.82-2.49)
Some college + 19 2.52 (1.16-5.43)
Employed
Yes 12 0.90 (0.52-1.56)
No 11 1.00
Residence
Metropolitan city 10 0.67 (0.34-1.31)
City 14 1.00 (0.52-1.93)
Rural 11 1.00
Monthly Income
<$1500 11 1.00
$1500-2999 12 0.85 (0.49-1.45)
>$3000 12 0.67 (0.34-1.30)
Self-reported health
Excellent/Very good 11 1.00
Good 14 1.45 (0.91-2.32)
Fair/Poor 10 1.14 (0.55-2.35)
Cancer screening is beneficial (mean ± SD) 1.6 ± 1.6 0.99 (0.68-1.45)
Alcohol Use
None in the past 30 days 9a 1.00
Light (1/week) 17 2.20 (1.32-3.68)
Moderate (2-6 day/week) 13 1.23 (0.68-2.40)
Heavy (7 day/week) 10 0.95 (0.36-2.49)
Exercise
Yes 15b 1.00
No 9 0.61 (0.39-0.94)
Having private cancer insurance
No 8b 1.00
Yes 14 2.25 (1.34-3.78)
Regular health check-up
No 6b 1.00
Yes 14 2.70 (1.57-4.67)
Note a p < .05; b p < .01BMC Infectious Diseases 2009, 9:185 http://www.biomedcentral.com/1471-2334/9/185
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With regard to health behavior factors, light drinkers were
more likely to have vaccinations than non drinkers. In
Korea, adult alcohol drinking has been increased over the
past 2 decades: Age-adjusted proportions of regular alco-
hol drinking among Koreans ages 20 to 59 years old were
49.1% in 1989 and 83.9% in 2005 [15]. Alcohol drinking
is regarded as a part of social gatherings in Korean culture.
Moreover, people learn the health benefits of having light
drinks, such as a glass of wine, in the media or magazines.
So, they perceive light drinking as a healthy lifestyle to
prevent heart disease. This suggests that light drinkers
(once a week) may be more health conscious than non-
drinkers. Future study is needed to explore this vaccina-
tion behavior with more refined measure of alcohol use,
such as quantity and frequency of alcohol use.
Consistent with previous cancer control behavior among
Koreans [16], health behavior (e.g., doing regular exercise,
having regular health check-up) is also important predic-
tor associated with HBV vaccinations. Those who are par-
ticipating preventive health behaviors are more likely to
have completed vaccinations than those who are not. This
may reflect that having good health behavior motivated
people to continue to have preventive health care services.
A salient issue for having HBV vaccinations is whether or
not Koreans understand and value a behavior which is
essentially preventive in nature. Even if most Koreans
have health insurance, more than two fifths did not seek
vaccinations because they did not know whether they had
needed vaccinations to protect against HBV infection. This
inadequate knowledge of the purpose of vaccinations is
an important barrier. This may indicate that many Kore-
ans are not familiar with the message of cancer prevention
through vaccinations. Similarly, the study of Asian Amer-
ican women found that a lack of familiarity with Western
preventive concepts is an important barrier to vaccina-
tions [17].
This study has several limitations. First, this study does
not have enough information regarding knowledge of
HBV screening or the risk of HBV infection which may
influence people to obtain HBV vaccinations. Therefore,
future studies of beliefs about HBV infection, knowledge
of HBV screening and vaccinations, and other barriers can
lead to a better understanding of the relationship between
these predictors and HBV vaccinations. Second, respond-
ents to the survey were volunteers. This may have intro-
duced a sampling bias of self-selection, because
participants who volunteered to answer our survey may
differ in important ways from those who did not. Third,
there may have been measurement errors as a result of
using self-reports of HBV infection status and HBV vacci-
nations. Several studies have established that self-reports
overestimate the prevalence of cancer screening [18,19].
In addition, a recent study of a multiethnic and multilin-
gual population showed consistent findings of overesti-
mated rates of self-reported cancer screening [20]. Fourth,
since the status of HBV infection is not based on HBV
serology, we do not know whether they had been exposed
to previous or ongoing infection with HBV (anti-HBc).
For those of anti-HBc positive patients with HBsAg-nega-
tive and anti-HBs-negative (we called 'unprotected'), they
may need vaccinations. However, there are other possibil-
ities. For example, somebody may have chronic HBV
infection despite the HBsAg-negative. It is important to
identify definitive HBV infection status based on the
results of serologic testing. Finally, the survey was admin-
istered by face-to-face interviews. The responses may be
subject to social desirability response bias, in which the
respondents try to answer as the interviewer would prefer.
Conclusion
The rate of HBV vaccination is still low among Koreans
ages over 40 years old; only half of respondents com-
pleted a series of vaccinations. In addition, two out of five
unprotected Koreans are not aware of the importance of
HBV vaccinations to prevent liver cancer. We need to
develop multiple strategies for secondary liver cancer pre-
vention to educate health care providers to increase HBV
screening as well as HBV vaccinations. The most impor-
tant correlates of HBV vaccinations were educational
attainment. This study points to the importance of devel-
oping educational strategies for liver cancer prevention
programs through vaccination among low educated pop-
ulations. Although national vaccination program has
been shown to be effective to reduce the prevalence of
HBsAg for those under 20 years of age, it does not help
adults who have already been exposed to HBV or chroni-
cally infected.
It is recommended that Korean adults start liver cancer
screening at age 40. However, the Korean public in general
lacks knowledge about the need for and benefits of liver
cancer screening (e.g., ultrasonography, serum α-fetopro-
tein). Implementation of the recommendations made
based on the results of this study can focus on primary
liver cancer prevention as well as secondary liver cancer
prevention. First, providing treatment and follow-up for
Table 5: The reason for not having HBV vaccinations (n = 718)
N%
Didn't know I needed this type of vaccination 317 44.1
Put if off/Laziness 115 16.0
Busy, No time to have the vaccination 93 13.0
HBV infection is not a severe health problem 76 10.6
I forgot to have vaccination 57 7.9
I am healthy 25 3.5
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HBV infected individuals is very important for primary
prevention. Next, identifying Korean adults who are
unprotected through screening tests and encouraging
them to have a series of vaccination is another aspect of
secondary prevention. These two important liver preven-
tion strategies will reduce liver cancer incidence and mor-
tality among this population.
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